Bortezomib and sirolimus inhibit the chronic active antibody-mediated rejection in experimental renal transplantation in the rat.

Bortezomib and sirolimus inhibit the chronic active antibody-mediated rejection in experimental renal transplantation in the rat.

Item
http://www.wikidata.org/entity/Q33577700
Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies treated with anticancer therapyBortezomib in late antibody-mediated kidney transplant rejection (BORTEJECT Study): study protocol for a randomized controlled trialInjured kidney endothelium is only marginally repopulated by cells of extrarenal origin.Drug-induced modulation of T lymphocytes as a potential mechanism of susceptibility to infections in patients with multiple myeloma during bortezomib therapy.Long-term gene therapy with thrombospondin 2 inhibits TGF-β activation, inflammation and angiogenesis in chronic allograft nephropathyPyrrolidine dithiocarbamate reduces the progression of total kidney volume and cyst enlargement in experimental polycystic kidney disease.The novel combination of sirolimus and bortezomib prevents graft-versus-host disease but maintains the graft-versus-leukemia effect after allogeneic transplantation.Targeting B cells and antibody in transplantationEmerging drugs for the treatment of transplant rejection.Targeting plasma cells with proteasome inhibitors: possible roles in treating myasthenia gravis?Transplant glomerulopathy: the interaction of HLA antibodies and endotheliumPilot conversion trial from mycophenolic acid to everolimus in ABO-incompatible kidney-transplant recipients with BK viruria and/or viremia.Hepatitis B virus reactivation in patients with multiple myeloma receiving bortezomib-containing regimens followed by autologous stem cell transplant.Effects of sotrastaurin, mycophenolic acid and everolimus on human B-lymphocyte function and activation.Amelioration of autoimmunity with an inhibitor selectively targeting all active centres of the immunoproteasome.
P2860

Bortezomib and sirolimus inhibit the chronic active antibody-mediated rejection in experimental renal transplantation in the rat.

Item
http://www.wikidata.org/entity/Q33577700
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Bortezomib and sirolimus inhib ...... al transplantation in the rat.
@ast
Bortezomib and sirolimus inhib ...... al transplantation in the rat.
@en
Bortezomib and sirolimus inhib ...... al transplantation in the rat.
@nl
type
label
Bortezomib and sirolimus inhib ...... al transplantation in the rat.
@ast
Bortezomib and sirolimus inhib ...... al transplantation in the rat.
@en
Bortezomib and sirolimus inhib ...... al transplantation in the rat.
@nl
prefLabel
Bortezomib and sirolimus inhib ...... al transplantation in the rat.
@ast
Bortezomib and sirolimus inhib ...... al transplantation in the rat.
@en
Bortezomib and sirolimus inhib ...... al transplantation in the rat.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Bortezomib and sirolimus inhib ...... al transplantation in the rat.
@en
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921